Pfizer Income After Taxes 2010-2024 | PFE

Pfizer income after taxes for the twelve months ending September 30, 2024 was $4.306B, a 59.02% decline year-over-year.

  • Pfizer annual income after taxes for 2023 was $2.173B, a 93.08% decline from 2022.
  • Pfizer annual income after taxes for 2022 was $31.401B, a 39.81% increase from 2021.
  • Pfizer annual income after taxes for 2021 was $22.459B, a 236.92% increase from 2020.

Pfizer Income After Taxes 2010-2024 | PFE

  • Pfizer annual income after taxes for 2023 was $2.173B, a 93.08% decline from 2022.
  • Pfizer annual income after taxes for 2022 was $31.401B, a 39.81% increase from 2021.
  • Pfizer annual income after taxes for 2021 was $22.459B, a 236.92% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B